...
首页> 外文期刊>Reactive & Functional Polymers >Carboxymethy1-beta-cyclodextrin grafted chitosan nanoparticles as oral delivery carrier of protein drugs
【24h】

Carboxymethy1-beta-cyclodextrin grafted chitosan nanoparticles as oral delivery carrier of protein drugs

机译:羧甲基1-β-环糊精接枝的壳聚糖纳米粒作为蛋白质药物的口服载体

获取原文
获取原文并翻译 | 示例

摘要

In this paper, the novel carboxymethyl-p-cyclodextrin grafted chitosan (CMCD-g-CS) nanoparticles were fabricated and their potential as oral delivery carrier of protein drugs was evaluated. The physicochemical properties of the prepared nanocarriers were characterized by Fourier transforms infrared spectroscopy, nuclear magnetic resonance, transmission electron microscopy and dynamic light scattering. Bovine serum albumin (BSA), a model protein drug, was loaded in prepared nanocarriers with ideal entrapment efficiency (EE) and loading content (LC). The drug release profiles of BSA loaded nanoparticles were studied in simulated gastric fluid (SGF), simulated intestinal fluid (SIF) and simulated colonic fluid (SCF). It was found that the drug loaded nanovehicles displayed a typical controlled sustained release profiles and the amount of BSA released from the nanocarriers was much higher in SIF and SCF than it in SGF. The research results suggested that the CMCD-g-CS nanoparticles had the potential as promising nanocarriers for oral delivery of protein drugs.
机译:本文制备了新型羧甲基-对-环糊精接枝的壳聚糖(CMCD-g-CS)纳米颗粒,并评价了其作为蛋白质药物口服载体的潜力。通过傅立叶变换红外光谱,核磁共振,透射电子显微镜和动态光散射对制备的纳米载体的理化性质进行了表征。牛血清白蛋白(BSA),一种模型蛋白药物,以理想的包封率(EE)和负载量(LC)加载到制备的纳米载体中。在模拟胃液(SGF),模拟肠液(SIF)和模拟结肠液(SCF)中研究了负载BSA的纳米颗粒的药物释放曲线。发现载有药物的纳米载体表现出典型的持续控制释放特征,并且在SIF和SCF中从纳米载体释放的BSA的量比在SGF中高得多。研究结果表明,CMCD-g-CS纳米颗粒具有作为蛋白质药物口服给药的有前途的纳米载体的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号